BV-500 NTM Program

N/A

Report date: 2025/04/30 14:07:24
NME

Base Information

Drug NameBV-500 NTM Program
Drug Alias NameBV-500
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsMycobacterium Infections, Nontuberculous
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerland
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBioVersys AG
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsMycobacterium Infections, Nontuberculous
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A